LSV Asset Management
ANIK icon

LSV Asset Management’s Anika Therapeutics ANIK Stock Holding History

LSV Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-109,917
Closed -$1.87M – 980
2013
Q2 		$1.87M Buy
+109,917
New +$1.59M 0.01% 575

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

LSV Asset Management's ANIK Position: Q3 2013 in Review

LSV Asset Management sold out of Anika Therapeutics (ANIK) in Q3 2013, closing a stake of 109,917 shares — an estimated $1.87M sold.

LSV Asset Management first reported a position in ANIK in Q2 2013 and held it in 1 quarter. The position peaked at $1.87M in Q2 2013. 111 funds tracked by Wall St. Rank hold ANIK as of Q3 2013.

  • LSV Asset Management reported no remaining Anika Therapeutics position as of Q3 2013 after selling out during the quarter.
  • LSV Asset Management sold 109,917 Anika Therapeutics shares in Q3 2013, an estimated $1.87M.
  • LSV Asset Management first reported a position in Anika Therapeutics in Q2 2013 and held it in 1 quarter.
  • LSV Asset Management's Anika Therapeutics position peaked at $1.87M in Q2 2013.
  • 111 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2013.

Based on LSV Asset Management's 13F filing for Q3 2013, filed 8 Nov 2013.